Fielmann AG (FLMNF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Fielmann AG (FLMNF) trades at $52.85 with AI Score 50/100 (Grade B). Fielmann Aktiengesellschaft operates a significant network of optical and hearing aid businesses across Europe, manufacturing and selling visual aids, hearing aids, and related accessories through both physical stores and online channels. Market cap: $4.44B, Sector: Healthcare.
Price live · AI analysis from Jun 13, 2026Analyst Coverage for FLMNF: FLMNF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FLMNF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
FLMNF: the 1 perspectives are evenly split.
How is this calculated? →Fielmann AG (FLMNF) Healthcare & Pipeline Overview
Fielmann AG is a prominent European retailer and manufacturer specializing in optical products and hearing aids, operating an extensive network of 693 stores and 78 smaller locations across Germany, Switzerland, Austria, Italy, Poland, Spain, and other European markets. The company leverages both brick-and-mortar and online sales channels to serve its diverse customer base.
What Is the Investment Thesis for FLMNF?
Fielmann AG presents a profile characterized by its established market position in the European optical and hearing aid sectors, supported by a robust physical store network and an expanding online presence. With a market capitalization of $4.44B and a P/E ratio of 18.2, the company demonstrates a stable valuation within its industry. Its financial health is underscored by an 8.4% profit margin and a 26.9% gross margin, indicating efficient operations and strong pricing power for its visual aids and hearing products. The company's dividend yield of 2.52% offers income potential, while a Beta of 0.61 suggests lower volatility compared to the broader market, appealing to investors seeking stability. Growth catalysts include continued expansion of its European store footprint, particularly in newer markets like Italy, Poland, and Spain, and the ongoing development of its online sales channels. The increasing demand for both optical and audiological solutions due to demographic shifts also provides a long-term tailwind. The company's integrated manufacturing and retail model contributes to its competitive advantage and value proposition.
Based on FMP financials and quantitative analysis
FLMNF Key Highlights
- Market capitalization stands at $4.26 billion, reflecting its significant presence in the European optical and hearing aid markets.
- The company maintains a P/E ratio of 18.2, indicating investor valuation relative to its earnings.
- Fielmann AG achieved an 8.4% profit margin, demonstrating effective cost management and profitability from its operations.
- A gross margin of 26.9% highlights the company's ability to generate substantial revenue above its cost of goods sold.
- Boasting a dividend yield of 2.52%, Fielmann provides returns to shareholders, coupled with a Beta of 0.61 suggesting lower market volatility.
Who Are FLMNF's Competitors?
FLMNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AHICF Asahi Intecc Co., Ltd. | $22.60 | +5.58% | $6.00B | 58 |
| CNVVY ConvaTec Group Plc | $11.74 | +0.41% | $5.74B | 43 |
| DSRLF DiaSorin S.p.A. | $84.10 | +13.27% | $4.16B | 52 |
| HKMPY Hikma Pharmaceuticals PLC | $41.03 | -0.49% | $4.32B | 45 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FLMNF's Key Strengths?
- Extensive retail network with 693 stores and 78 smaller locations across Europe as of December 31, 2021, providing broad market access.
- Vertically integrated business model, encompassing manufacturing and direct sales of optical and hearing aid products.
- Established brand presence and long operating history since 1972, fostering customer trust and recognition.
- Diversified product offering including visual aids, sunglasses, contact lenses, and hearing aids, catering to a wide customer base.
What Are FLMNF's Weaknesses?
- Reliance on the European market for the majority of its operations, potentially limiting global growth opportunities.
- Physical store-heavy model may incur higher operational costs compared to pure-play online retailers.
- Unknown disclosure status for its OTC listing, potentially impacting investor confidence and transparency.
- Exposure to regional economic fluctuations and consumer spending habits across its diverse European markets.
What Could Drive FLMNF Stock Higher?
- Continued expansion of the European store network, particularly in growth markets like Italy, Poland, and Spain, could drive increased revenue and market share.
- Strategic investments in enhancing the online sales platform and digital customer experience are expected to capture a larger share of the e-commerce optical and hearing aid market.
- Further development and marketing of the hearing aid business, capitalizing on demographic trends and increasing demand for audiological solutions, could open new growth avenues.
- Operational efficiencies and supply chain optimization within its integrated manufacturing and retail model could lead to improved profit margins and overall financial performance.
What Are the Key Risks for FLMNF?
- Intense competition within the European optical and hearing aid markets from both large chains and independent retailers could pressure pricing and market share.
- Economic downturns or shifts in consumer discretionary spending across its diverse European operating regions could negatively impact sales volumes and profitability.
- Regulatory changes or increased compliance requirements in the healthcare and retail sectors across multiple countries could lead to higher operational costs or restrictions.
- The 'Unknown' disclosure status for its OTC listing may deter institutional investors and limit access to capital markets, impacting growth initiatives.
- Fluctuations in currency exchange rates across its European operations could affect reported revenues and profits when converted to a common reporting currency.
What Are the Growth Opportunities for FLMNF?
- **Expansion of European Retail Footprint:** Fielmann AG has a well-established presence across Europe, with 693 stores and 78 smaller locations as of December 31, 2021. Continued strategic expansion into underserved regions or further penetration within existing markets like Italy (43 stores), Poland (37 stores), and Spain (87 stores) presents a significant growth avenue. By opening new stores and optimizing existing ones, Fielmann can capture additional market share and extend its brand reach, leveraging its proven retail model to tap into growing consumer demand for optical and hearing aid products across the continent. This organic growth strategy is a fundamental driver for increasing sales volumes and overall revenue.
- **Enhancement of Online Sales Channels:** The company already offers its products through online stores, providing a crucial digital complement to its physical retail network. Investing further in e-commerce capabilities, including user experience improvements, digital marketing, and efficient logistics, can significantly boost sales. The online optical and hearing aid market is experiencing substantial growth, driven by consumer preference for convenience and broader product selection. By strengthening its digital presence, Fielmann can reach a wider customer base beyond the immediate vicinity of its physical stores, capitalize on cross-border e-commerce opportunities, and cater to the evolving purchasing habits of modern consumers, thereby unlocking a substantial market segment.
- **Deepening Penetration in the Hearing Aid Market:** Fielmann AG's business model explicitly includes the operation of hearing aid businesses and the sale of hearing aids and accessories. The global hearing aid market is projected to experience consistent growth, fueled by an aging population and increased awareness of hearing health. By expanding its audiology services, offering a wider range of hearing aid technologies, and integrating these services more closely with its optical offerings, Fielmann can capture a larger share of this growing market. This diversification within the healthcare sector provides a resilient growth driver, leveraging its existing customer base and retail infrastructure to address a distinct yet related health need.
- **International Market Share Consolidation:** With a presence in multiple European countries, Fielmann has the opportunity to consolidate its market share in regions where it has a developing footprint. For instance, in countries like Slovenia (32 stores) and the 'rest of Europe' (15 stores as of Dec 31, 2021), there is potential to increase brand recognition and customer loyalty through targeted marketing, localized product offerings, and service enhancements. By focusing on deepening its roots in these markets, Fielmann can transition from an initial market entry phase to a more dominant position, driving sustained revenue growth and operational efficiencies through economies of scale in procurement and distribution across its European network.
- **Integrated Service Model and Customer Experience:** Fielmann's extensive network of optical and hearing aid businesses provides a strong foundation for developing an integrated service model that enhances the overall customer experience. By offering comprehensive eye exams, personalized fitting services for glasses and contact lenses, and professional audiological assessments and hearing aid adjustments, the company can differentiate itself from competitors. This focus on end-to-end service, leveraging its skilled employees and physical locations, fosters customer loyalty and repeat business. Investing in advanced diagnostic tools and training for its 20,221 employees ensures high-quality service, positioning Fielmann as a trusted provider and driving organic growth through strong customer retention and referrals.
What Opportunities Does FLMNF Have?
- Further expansion into new or less saturated European markets for both optical and hearing aid businesses.
- Enhanced development and integration of its online sales channels to capture a larger share of the e-commerce market.
- Capitalizing on the growing demand for hearing aids driven by an aging population and increased health awareness.
- Potential for product innovation and service enhancements within its core optical and audiological offerings.
What Threats Does FLMNF Face?
- Intense competition from both large international optical chains and independent local providers.
- Regulatory changes in the healthcare and retail sectors across various European countries.
- Disruption from online-only competitors offering lower prices or more convenient digital services.
- Economic downturns impacting consumer discretionary spending on optical and hearing aid products.
What Are FLMNF's Competitive Advantages?
- **Extensive Retail Network:** A vast physical footprint of 693 stores and 78 smaller locations as of December 31, 2021, across Europe provides significant market access and brand visibility.
- **Integrated Business Model:** Combining manufacturing with retail operations allows for cost control, quality assurance, and efficient supply chain management.
- **Brand Recognition and Trust:** A long operating history since 1972, coupled with its widespread presence, has likely built strong brand recognition and customer trust in its core markets.
- **Dual-Channel Strategy:** The combination of brick-and-mortar stores for personalized service and online stores for convenience creates a comprehensive customer engagement model that is difficult for pure-play competitors to replicate.
What Does FLMNF Do?
Fielmann Aktiengesellschaft, a subsidiary of Korva SE, is a leading European enterprise engaged in the investment in and operation of optical and hearing aid businesses. Founded in 1972 and headquartered in Hamburg, Germany, the company has evolved from its origins to establish a significant market presence across the continent. Fielmann manufactures and sells a comprehensive range of visual aids and other optical products, including various styles of glasses, frames, high-quality lenses, fashionable sunglasses, contact lenses, and essential accessories. Beyond optical goods, the company has strategically diversified into the hearing aid market, offering a selection of hearing aids and related accessories to address a broader spectrum of customer needs within the healthcare sector. As of December 31, 2021, Fielmann's operational footprint was substantial, encompassing 693 stores spread across multiple European countries. This network included 610 stores in its home market of Germany, 45 in Switzerland, 38 in Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and an additional 15 locations across the rest of Europe. Complementing this extensive physical retail presence, the company also operates 78 smaller locations in Eastern Europe, further extending its reach. In line with modern retail trends, Fielmann Aktiengesellschaft has also established online stores, providing customers with convenient access to its product offerings and services digitally. This dual-channel approach allows the company to cater to varying consumer preferences, ensuring accessibility and market penetration across its operational geographies.
What Products and Services Does FLMNF Offer?
- Operates optical retail stores across Europe, offering a wide range of visual aids.
- Manufactures and sells glasses, including frames and lenses, catering to various customer preferences.
- Provides sunglasses and contact lenses along with related accessories.
- Engages in the hearing aid business, selling hearing aids and associated accessories.
- Manages an extensive network of 693 stores and 78 smaller locations as of December 31, 2021, primarily in Germany, Switzerland, Austria, Italy, Poland, and Spain.
- Offers products and services through online stores, complementing its brick-and-mortar presence.
- Invests in and operates businesses within the optical and hearing aid sectors.
- Sells various merchandise related to visual and audiological health.
How Does FLMNF Make Money?
- **Integrated Retail and Manufacturing:** Fielmann operates a vertically integrated model, manufacturing visual aids and selling them directly to consumers through its extensive store network and online channels.
- **Dual-Channel Sales Strategy:** The company generates revenue through both its physical retail stores, offering personalized consultation and fitting services, and its online stores, providing convenience and broader access to products.
- **Product Diversification:** Revenue streams are diversified across optical products (glasses, lenses, sunglasses, contact lenses) and hearing aids, catering to a broader healthcare market segment.
- **Geographic Expansion:** Growth is pursued through the strategic expansion and operation of new stores in existing and new European markets, increasing market penetration and customer reach.
What Industry Does FLMNF Operate In?
Fielmann AG operates within the Medical - Instruments & Supplies industry, specifically focusing on the optical and hearing aid segments of the broader Healthcare sector. This industry is characterized by steady demand driven by an aging global population and increasing awareness of vision and hearing health. The European market, where Fielmann primarily operates, is mature but offers growth opportunities through demographic shifts and technological advancements in product offerings. The competitive landscape includes both large international chains and independent opticians and audiologists. Fielmann distinguishes itself through its extensive store network (693 stores and 78 smaller locations as of Dec 31, 2021), integrated manufacturing capabilities, and a dual-channel retail strategy encompassing physical and online stores. Market trends indicate a growing preference for convenience, personalized service, and a diverse product range, areas where Fielmann's established presence and operational model provide a competitive edge.
Who Are FLMNF's Key Customers?
- Individuals seeking prescription glasses, including a wide range of frames and lenses.
- Consumers looking for non-prescription sunglasses and contact lenses.
- Customers requiring hearing aids and related audiological services and accessories.
- Individuals across various age groups in European countries, including Germany, Switzerland, Austria, Italy, Poland, and Spain.
FY2026 estForward Outlook
Wall Street analysts project Fielmann AG revenue of about $2.56B for fiscal 2026, with EPS near $2.64. The estimate reflects 8 contributing analysts.
FLMNF Valuation & Market Position
With a $4.44B market cap, Fielmann AG sits in the mid-cap segment of the market. Relative to its peer group, FLMNF's quantitative score of 50/100 is roughly in line with the peer average of 53/100.
ROE 22%Key Financial Metrics
Return on equity for Fielmann AG stands at 21.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.6%, showing how much profit it generates from its asset base. FLMNF trades at a trailing price-to-earnings ratio of 18.15, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.19 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.6%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Fielmann AG's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.48 places it in the safe zone, indicating low near-term bankruptcy risk.
Company Profile
Fielmann AG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Hamburg, DE. The company is led by CEO Marc Fielmann. FLMNF has traded publicly since 2013.
FLMNF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Extensive retail network with 693 stores and 78 smaller locations across Europe as of December 31, 2021, providing broad market access.
- Vertically integrated business model, encompassing manufacturing and direct sales of optical and hearing aid products.
- Established brand presence and long operating history since 1972, fostering customer trust and recognition.
- Diversified product offering including visual aids, sunglasses, contact lenses, and hearing aids, catering to a wide customer base.
Bear Case
- Reliance on the European market for the majority of its operations, potentially limiting global growth opportunities.
- Physical store-heavy model may incur higher operational costs compared to pure-play online retailers.
- Unknown disclosure status for its OTC listing, potentially impacting investor confidence and transparency.
- Exposure to regional economic fluctuations and consumer spending habits across its diverse European markets.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FLMNF Latest News
No recent news available for FLMNF.
FLMNF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FLMNF.
Price Targets
Wall Street price target analysis for FLMNF.
FLMNF MoonshotScore
What does this score mean?
The MoonshotScore rates FLMNF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Marc Fielmann
CEO
Marc Fielmann leads Fielmann Aktiengesellschaft as its CEO, overseeing a workforce of 20,221 employees. His leadership is central to the company's strategic direction and operational execution within the competitive European optical and hearing aid markets. While specific details on his educational background or prior roles before assuming the CEO position are not provided in the source data, his current role implies extensive experience and a deep understanding of the retail, manufacturing, and healthcare sectors relevant to Fielmann's business. His tenure as CEO places him at the helm of a company with a long-standing history and a significant market footprint across multiple European countries.
Track Record: Under Marc Fielmann's leadership, Fielmann AG continues to manage its extensive network of 693 stores and 78 smaller locations as of December 31, 2021, ensuring the ongoing operation and investment in optical and hearing aid businesses. His strategic oversight includes the continued manufacturing and sale of visual aids and hearing aids, alongside the expansion and maintenance of the company's online sales channels. His management is responsible for guiding the company's performance, which includes maintaining a profit margin of 8.4% and a gross margin of 26.9% as reported in the financials.
FLMNF OTC Market Information
FLMNF trades on the 'OTC Other' tier of the OTC market. This tier represents the lowest level of the OTC market, typically for companies that do not meet the disclosure or financial requirements for higher tiers like OTCQX or OTCQB. Companies in the 'OTC Other' tier may have limited public information available, which can make due diligence more challenging for investors. Unlike exchange-listed stocks on the NYSE or NASDAQ, which have stringent listing standards for financial reporting and corporate governance, 'OTC Other' companies face minimal regulatory oversight regarding disclosure, leading to a less transparent trading environment.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Limited Disclosure:** The 'Unknown' disclosure status means investors have limited access to timely and comprehensive financial information, making it difficult to assess the company's true financial health and operational performance.
- **Lower Liquidity:** Trading on the 'OTC Other' tier typically results in lower trading volumes and wider bid-ask spreads, which can make it challenging to buy or sell shares efficiently and at fair market prices.
- **Price Volatility:** Stocks on lower OTC tiers can be subject to higher price volatility due to lower liquidity, limited information, and less institutional interest, leading to potentially significant and rapid price swings.
- **Regulatory Oversight:** 'OTC Other' companies are subject to minimal regulatory oversight from bodies like the SEC, which means fewer protections for investors compared to exchange-listed securities.
- **Information Asymmetry:** The lack of robust disclosure requirements can create information asymmetry, where insiders may have access to more critical information than public investors, potentially leading to unfair trading advantages.
- Verify the company's latest available financial statements and annual reports, even if disclosure is limited.
- Research the company's business operations, products, and market position thoroughly using independent sources.
- Assess the management team's background, experience, and track record, as this is crucial in less regulated environments.
- Analyze trading volume and bid-ask spreads to understand potential liquidity challenges and transaction costs.
- Investigate any news, press releases, or corporate actions that may be publicly available, however scarce.
- Understand the company's ownership structure, especially its relationship with Korva SE, to identify potential conflicts of interest.
- Consult with a financial advisor experienced in OTC markets due to the unique risks involved.
- **Established Operating History:** Fielmann AG was founded in 1972, indicating a long operational track record rather than a newly formed speculative venture.
- **Significant Employee Base:** The company employs 20,221 individuals, suggesting a substantial and active business operation.
- **Large Market Capitalization:** A market cap of $4.44B indicates a considerable company size, which is uncommon for purely speculative OTC entities.
- **Extensive European Store Network:** Operating 693 stores and 78 smaller locations across multiple European countries signifies a tangible and widespread business presence.
- **Subsidiary of Korva SE:** Being a subsidiary of another entity provides a layer of corporate structure and potential oversight, even if specific details are not provided.
What Investors Ask About Fielmann AG (FLMNF) — Healthcare
What does Fielmann AG do?
Fielmann Aktiengesellschaft is a prominent European company specializing in the optical and hearing aid sectors. It manufactures and sells a wide array of visual aids, including various types of glasses, frames, lenses, sunglasses, and contact lenses, along with related accessories. Additionally, the company operates in the hearing aid business, offering hearing aids and their accessories. As of December 31, 2021, Fielmann managed an extensive retail network of 693 stores and 78 smaller locations across numerous European countries, including Germany, Switzerland, Austria, Italy, Poland, and Spain. The company also extends its reach through online stores, providing a comprehensive dual-channel approach to serving its customer base.
What are the main risks for FLMNF?
Fielmann AG faces several key risks, including intense competition in the fragmented European optical and hearing aid markets, which could exert pressure on pricing and market share. Economic volatility and changes in consumer spending habits across its diverse European operating regions pose a continuous threat to sales volumes and profitability. Furthermore, as an OTC-listed stock with an 'Unknown' disclosure status, FLMNF is exposed to risks associated with limited transparency, potentially deterring investors and impacting its ability to raise capital. Regulatory changes in the healthcare and retail sectors across its multiple operating countries could also introduce new compliance costs or operational restrictions, affecting the company's financial performance and strategic flexibility.
How does Fielmann AG leverage its extensive European store network?
Fielmann AG leverages its extensive European store network, comprising 693 stores and 78 smaller locations as of December 31, 2021, as a core competitive advantage. This widespread physical presence allows the company to offer personalized customer service, including eye examinations, precise fittings for glasses and contact lenses, and professional hearing aid consultations, which are crucial for customer satisfaction and retention in the optical and audiological sectors. The network ensures broad market access and high brand visibility across key European economies like Germany, Switzerland, Austria, Italy, Poland, and Spain. This physical infrastructure also supports an integrated service model, fostering customer loyalty and providing a tangible touchpoint that complements its growing online sales channels, thereby enhancing its overall market penetration and customer experience.
What is Fielmann AG's strategy for growth in the hearing aid market?
Fielmann AG's strategy for growth in the hearing aid market is integrated within its broader healthcare retail operations, leveraging its existing extensive store network and customer base. The company actively engages in the operation of hearing aid businesses and the sale of hearing aids and accessories, indicating a commitment to this segment. Growth is likely driven by expanding the availability of audiological services within its existing stores, offering a diverse range of hearing aid technologies to cater to varying customer needs, and potentially increasing the number of dedicated hearing aid specialists. Capitalizing on the demographic trend of an aging population, which naturally increases demand for hearing solutions, Fielmann aims to deepen its penetration in this market by providing accessible, professional, and comprehensive audiological care alongside its optical services, thereby diversifying its revenue streams and addressing a critical healthcare need.
What are the key factors to evaluate for FLMNF?
Fielmann AG (FLMNF) holds an AI score of 50/100 (moderate). P/E: 18.2x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does FLMNF data refresh on this page?
FLMNF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FLMNF's recent stock price performance?
Fielmann AG (FLMNF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Extensive retail network with 693 stores and 78 smaller locations across Europe as of December 31, 2021, providing broad market access. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FLMNF overvalued or undervalued right now?
Fielmann AG (FLMNF) trades at 18.2x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- CEO's title inferred as 'CEO' based on 'managing 20221 employees' as explicit title was not provided.
- CEO's background and track record are based solely on the provided information, which is limited.
- Specific market sizes and timelines for growth opportunities are not explicitly stated in the source data and are inferred based on general industry knowledge and company's operational context.
- The 'Unknown' disclosure status for OTC trading limits the depth of analysis for certain financial and operational aspects.